| | | | | Experimental host and age | Passage history and strain | Inoculation Route-Dose | Evidence of infection | AST (days) | Titer log10/ml | |
|---|
|
| | Mice (nb) | M.E. serum | ic | Sickness and death | 5-7 | | | | Mice (nb) | M.E. serum | ip | Sickness and death | 5-9 | | | | Mice (nb) | | sc | | | | | | Mice (wn) | M.E. serum | ic | Sickness and death | 4-5 | | | | Mice (wn) | M.E. serum | ip | Sickness and death | 4-5 | | | | guinea pig | M.E. serum | ip | Fever, lethargy, sporadic deaths | 12 | | | | | | | | | | | | guinea pig | M.E. serum, GP3 Vero 1 | ip | Death | 9 | 6.5 (liver) | | | | | | | | | | | monkeys(vervet) | M.E. serum, GP2 | ip | Fever, death | 6 | 6.0 (serum) | | | | | | | | | | | monkeys(rhesus) | M.E. serum, GP3 | ip | Fever, death | 5-8 | 6.5 (blood) | | | | | | | | | | | monkeys (cynomolgus) | M.E. serum, GP3 | ip | Fever, death | 5-8 | 7.5 (liver) | | | | | | | | | | | | | | | | 7.5 (spleen) | | | | | | | | | | | | | | | | | |
| | |
|
